Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jop Mostert

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2019
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data setsMarcus W Koch, Jop Mostert, Bernard Uitdehaag, et al.
Journal of Neurology|February 24, 2007
Tremor in multiple sclerosisMarcus Koch, Jop Mostert, Dorothea Heersema, et al.
Trends in Pharmacological Sciences|April 23, 2004
Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosisJacques De Keyser, Esther Zeinstra, Jop Mostert, et al.
Journal of the Neurological Sciences|March 3, 2007
Progression in multiple sclerosis: further evidence of an age dependent processMarcus Koch, Jop Mostert, Dorothea Heersema, et al.
Journal of the Neurological Sciences|December 26, 2006
Plasma S100beta and NSE levels and progression in multiple sclerosisMarcus Koch, Jop Mostert, Dorothea Heersema, et al.
Annals of Neurology|August 19, 2007
Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosisMarcus Koch, Jop Mostert, Jacques De Keyser, et al.
The Cochrane Database of Systematic Reviews|February 18, 2011
Pharmacologic treatment of depression in multiple sclerosisMarcus W Koch, Arjon Glazenborg, Maarten Uyttenboogaart, et al.
Journal of Neurology|May 11, 2020
Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependentMarcus W Koch, Jop Mostert, Jamie Greenfield, et al.
Neurochemistry International|February 25, 2010
Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosisJacques De Keyser, Guy Laureys, Frauke Demol, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Progression in familial and nonfamilial MSMarcus Koch, Maarten Uyttenboogaart, Marco Heerings, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2019
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data setsMarcus W Koch, Jop Mostert, Bernard Uitdehaag, et al.
Journal of Neurology|February 24, 2007
Tremor in multiple sclerosisMarcus Koch, Jop Mostert, Dorothea Heersema, et al.
Trends in Pharmacological Sciences|April 23, 2004
Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosisJacques De Keyser, Esther Zeinstra, Jop Mostert, et al.
Journal of the Neurological Sciences|March 3, 2007
Progression in multiple sclerosis: further evidence of an age dependent processMarcus Koch, Jop Mostert, Dorothea Heersema, et al.
Journal of the Neurological Sciences|December 26, 2006
Plasma S100beta and NSE levels and progression in multiple sclerosisMarcus Koch, Jop Mostert, Dorothea Heersema, et al.
Annals of Neurology|August 19, 2007
Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosisMarcus Koch, Jop Mostert, Jacques De Keyser, et al.
The Cochrane Database of Systematic Reviews|February 18, 2011
Pharmacologic treatment of depression in multiple sclerosisMarcus W Koch, Arjon Glazenborg, Maarten Uyttenboogaart, et al.
Journal of Neurology|May 11, 2020
Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependentMarcus W Koch, Jop Mostert, Jamie Greenfield, et al.
Neurochemistry International|February 25, 2010
Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosisJacques De Keyser, Guy Laureys, Frauke Demol, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Progression in familial and nonfamilial MSMarcus Koch, Maarten Uyttenboogaart, Marco Heerings, et al.
Pageof 5